Polarean Imaging plc announces that the Company has delivered and installed its latest research unit order for a 9820 Xenon Polariser system from the University of Iowa Hospitals and Clinics (“UI Hospitals & Clinics”).
24 December 2019
Polarean Imaging Plc
(“Polarean” or the “Company”)
New System Delivery and Installation
Polarean Imaging plc (AIM: POLX), the medical-imaging technology company, with a proprietary drug-device combination product for the magnetic resonance imaging (MRI) market, announces that the Company has delivered and installed its latest research unit order for a 9820 Xenon Polariser system from the University of Iowa Hospitals and Clinics (“UI Hospitals & Clinics”).
The University of Iowa Hospitals and Clinics is Iowa’s only comprehensive academic medical centre; an 811-bed hospital that annually admits about 37,000 patients for in-patient hospital care. For more information: https://uihc.org/basic-facts
The total number of the Company’s polarisers that are either installed or on order remains 25.
Richard Hullihen, CEO of Polarean, said: “I am delighted that we have delivered and installed another polariser, to be used by pulmonology researchers at this well-regarded teaching hospital. The University of Iowa has a long history in medical imaging research and we are excited at the prospect of beginning a new chapter in hyperpolarized xenon cardiopulmonary imaging with them.”
This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.
Enquiries:
| Polarean Imaging plc | www.polarean.com / www.polarean-ir.com | |||
| Richard Hullihen, Chief Executive Officer | Via Walbrook PR | |||
| Richard Morgan, Chairman | ||||
| SP Angel Corporate Finance LLP | Tel: +44 (0)20 3470 0470 | |||
David Hignell, Soltan Tagiev (Corporate Finance) Vadim Alexandre / Rob Rees (Corporate Broking) | ||||
| Walbrook PR | Tel: +44 (0)20 7933 8780 or polarean@walbrookpr.com | |||
| Paul McManus / Anna Dunphy | Mob: +44 (0)7980 541 893 / +44 (0)7879 741 001 | |||
